Strategies to treat sepsis: old and new
Clinical Investigation · 2011
DOI: 10.4155/cli.10.19 ↗At a glance
Journal article in Clinical Investigation, 2011. Written by Steven P LaRosa and 1 co-authors. Cited 2 times so far (Crossref); 123 references.
Topics: Sepsis
Abstract (original language)
Despite advances in critical care, the incidence and mortality from severe sepsis remains unacceptably high. Numerous strategies focusing on the pathophysiology of severe sepsis are being pursued. Bacteria and bacterial products that trigger sepsis are being targeted via antibodies, signaling antagonists and filtration columns. Excessive inflammation is being addressed with the use of specific blocking antibodies for injurious cytokines as well as devices and molecules that address the proinflammatory cytokine pathways. Injury to the gut and the endothelial lining that occur during sepsis and propagate inflammation and organ dysfunction is being addressed with protective molecules. Replacement strategies for protective molecules exhausted during the sepsis episode are being examined. Finally, strategies to reverse the immunosuppression of sepsis are being revived.
Cite
APA
LaRosa, S. P., & Opal, S. M. (2011). Strategies to treat sepsis: old and new. Clinical Investigation. https://doi.org/10.4155/cli.10.19
Vancouver
LaRosa SP, Opal SM. Strategies to treat sepsis: old and new. Clinical Investigation. 2011. doi:10.4155/cli.10.19
BibTeX
@article{LaRosa2011,
author = {LaRosa, Steven P and Opal, Steven M},
title = {Strategies to treat sepsis: old and new},
journal = {Clinical Investigation},
year = {2011},
doi = {10.4155/cli.10.19}
}
EUVIMED